Oil & Gas Equipment & Services
Compare Stocks
5 / 10Stock Comparison
HLX vs OII vs TDW vs CLOV vs ACDC
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Equipment & Services
Oil & Gas Equipment & Services
Medical - Healthcare Plans
Oil & Gas Equipment & Services
HLX vs OII vs TDW vs CLOV vs ACDC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services | Medical - Healthcare Plans | Oil & Gas Equipment & Services |
| Market Cap | $1.48B | $3.77B | $4.10B | $1.80B | $1.32B |
| Revenue (TTM) | $1.30B | $2.80B | $1.35B | $2.21B | $1.79B |
| Net Income (TTM) | $14M | $339M | $298M | $-57M | $-433M |
| Gross Margin | 10.8% | 20.0% | 22.4% | 18.2% | -0.3% |
| Operating Margin | 3.4% | 10.3% | 20.0% | -2.8% | -12.5% |
| Forward P/E | 36.2x | 21.0x | 23.8x | 89.7x | — |
| Total Debt | $630M | $487M | $655M | $0.00 | $1.14B |
| Cash & Equiv. | $445M | $689M | $579M | $78M | $23M |
HLX vs OII vs TDW vs CLOV vs ACDC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 22 | May 26 | Return |
|---|---|---|---|
| Helix Energy Soluti… (HLX) | 100 | 216.6 | +116.6% |
| Oceaneering Interna… (OII) | 100 | 297.5 | +197.5% |
| Tidewater Inc. (TDW) | 100 | 323.6 | +223.6% |
| Clover Health Inves… (CLOV) | 100 | 130.0 | +30.0% |
| ProFrac Holding Cor… (ACDC) | 100 | 39.9 | -60.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HLX vs OII vs TDW vs CLOV vs ACDC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HLX is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.78
- 37.9% 10Y total return vs OII's 20.6%
OII is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 4.6%, EPS growth 142.4%, 3Y rev CAGR 10.5%
- Better valuation composite
TDW carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.71, Low D/E 48.1%, current ratio 2.90x
- Beta 0.71, current ratio 2.90x
- 22.2% margin vs ACDC's -24.2%
- +96.4% vs CLOV's +1.8%
CLOV ranks third and is worth considering specifically for growth.
- 40.3% revenue growth vs ACDC's -11.4%
ACDC is the clearest fit if your priority is stability.
- Beta 0.51 vs CLOV's 1.36
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.3% revenue growth vs ACDC's -11.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 22.2% margin vs ACDC's -24.2% | |
| Stability / Safety | Beta 0.51 vs CLOV's 1.36 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +96.4% vs CLOV's +1.8% | |
| Efficiency (ROA) | 13.4% ROA vs ACDC's -16.2%, ROIC 15.2% vs -4.6% |
HLX vs OII vs TDW vs CLOV vs ACDC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HLX vs OII vs TDW vs CLOV vs ACDC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TDW leads in 1 of 6 categories
HLX leads 1 • OII leads 1 • CLOV leads 0 • ACDC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TDW leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OII is the larger business by revenue, generating $2.8B annually — 2.2x HLX's $1.3B. TDW is the more profitable business, keeping 22.2% of every revenue dollar as net income compared to ACDC's -24.2%. On growth, CLOV holds the edge at +61.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.3B | $2.8B | $1.3B | $2.2B | $1.8B |
| EBITDAEarnings before interest/tax | $177M | $394M | $477M | -$60M | $183M |
| Net IncomeAfter-tax profit | $14M | $339M | $298M | -$57M | -$433M |
| Free Cash FlowCash after capex | $167M | $240M | $282M | $55M | $2M |
| Gross MarginGross profit ÷ Revenue | +10.8% | +20.0% | +22.4% | +18.2% | -0.3% |
| Operating MarginEBIT ÷ Revenue | +3.4% | +10.3% | +20.0% | -2.8% | -12.5% |
| Net MarginNet income ÷ Revenue | +1.1% | +12.1% | +22.2% | -2.6% | -24.2% |
| FCF MarginFCF ÷ Revenue | +12.9% | +8.6% | +20.9% | +2.5% | +0.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.6% | +2.7% | -2.2% | +61.0% | -25.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.5% | -26.5% | -85.5% | — | -3.3% |
Valuation Metrics
HLX leads this category, winning 2 of 6 comparable metrics.
Valuation Metrics
At 10.8x trailing earnings, OII trades at a 77% valuation discount to HLX's 47.9x P/E. On an enterprise value basis, HLX's 6.6x EV/EBITDA is more attractive than OII's 8.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.5B | $3.8B | $4.1B | $1.8B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $3.6B | $4.2B | $1.7B | $2.4B |
| Trailing P/EPrice ÷ TTM EPS | 47.86x | 10.84x | 12.40x | -20.41x | -3.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 36.15x | 20.98x | 23.76x | 89.66x | — |
| PEG RatioP/E ÷ EPS growth rate | 4.75x | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 6.59x | 8.78x | 7.55x | — | 8.61x |
| Price / SalesMarket cap ÷ Revenue | 1.15x | 1.36x | 3.03x | 0.93x | 0.68x |
| Price / BookPrice ÷ Book value/share | 0.94x | 3.56x | 3.03x | 5.81x | 1.32x |
| Price / FCFMarket cap ÷ FCF | 12.29x | 18.16x | 11.59x | — | 67.20x |
Profitability & Efficiency
OII leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
OII delivers a 34.3% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $-48 for ACDC. HLX carries lower financial leverage with a 0.40x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACDC's 1.30x. On the Piotroski fundamental quality scale (0–9), TDW scores 8/9 vs CLOV's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.9% | +34.3% | +23.8% | -17.1% | -48.5% |
| ROA (TTM)Return on assets | +0.5% | +13.3% | +13.4% | -9.6% | -16.2% |
| ROICReturn on invested capital | +2.7% | +23.4% | +15.2% | -34.0% | -4.6% |
| ROCEReturn on capital employed | +2.8% | +17.7% | +15.2% | -24.5% | -6.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 8 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.40x | 0.45x | 0.48x | — | 1.30x |
| Net DebtTotal debt minus cash | $185M | -$201M | $76M | -$78M | $1.1B |
| Cash & Equiv.Liquid assets | $445M | $689M | $579M | $78M | $23M |
| Total DebtShort + long-term debt | $630M | $487M | $655M | $0 | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | 3.17x | 7.65x | 4.05x | — | -2.15x |
Total Returns (Dividends Reinvested)
Evenly matched — TDW and CLOV each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TDW five years ago would be worth $56,020 today (with dividends reinvested), compared to $4,020 for ACDC. Over the past 12 months, TDW leads with a +96.4% total return vs CLOV's +1.8%. The 3-year compound annual growth rate (CAGR) favors CLOV at 52.8% vs ACDC's -12.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +57.0% | +52.3% | +57.7% | +44.0% | +80.2% |
| 1-Year ReturnPast 12 months | +51.8% | +90.3% | +96.4% | +1.8% | +15.9% |
| 3-Year ReturnCumulative with dividends | +49.8% | +129.9% | +84.1% | +256.8% | -32.3% |
| 5-Year ReturnCumulative with dividends | +90.0% | +148.3% | +460.2% | -49.1% | -59.8% |
| 10-Year ReturnCumulative with dividends | +37.9% | +20.6% | -65.2% | -66.0% | -59.8% |
| CAGR (3Y)Annualised 3-year return | +14.4% | +32.0% | +22.6% | +52.8% | -12.2% |
Risk & Volatility
Evenly matched — OII and ACDC each lead in 1 of 2 comparable metrics.
Risk & Volatility
ACDC is the less volatile stock with a 0.51 beta — it tends to amplify market swings less than CLOV's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OII currently trades 94.3% from its 52-week high vs ACDC's 68.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 1.02x | 0.71x | 1.36x | 0.51x |
| 52-Week HighHighest price in past year | $10.75 | $40.12 | $93.13 | $3.92 | $10.70 |
| 52-Week LowLowest price in past year | $5.52 | $18.45 | $38.24 | $1.58 | $3.08 |
| % of 52W HighCurrent price vs 52-week peak | +93.5% | +94.3% | +88.4% | +88.5% | +68.0% |
| RSI (14)Momentum oscillator 0–100 | 57.6 | 59.0 | 46.0 | 82.3 | 58.0 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 1.2M | 793K | 6.1M | 1.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: HLX as "Buy", OII as "Hold", TDW as "Hold", CLOV as "Hold", ACDC as "Hold". Consensus price targets imply 39.3% upside for HLX (target: $14) vs -17.6% for ACDC (target: $6).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $14.00 | $36.50 | $101.50 | $3.33 | $6.00 |
| # AnalystsCovering analysts | 22 | 44 | 26 | 9 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +1.2% | +2.2% | +3.1% | 0.0% |
TDW leads in 1 of 6 categories (Income & Cash Flow). HLX leads in 1 (Valuation Metrics). 2 tied.
HLX vs OII vs TDW vs CLOV vs ACDC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HLX or OII or TDW or CLOV or ACDC a better buy right now?
For growth investors, Clover Health Investments, Corp.
(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus -11. 4% for ProFrac Holding Corp. (ACDC). Oceaneering International, Inc. (OII) offers the better valuation at 10. 8x trailing P/E (21. 0x forward), making it the more compelling value choice. Analysts rate Helix Energy Solutions Group, Inc. (HLX) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HLX or OII or TDW or CLOV or ACDC?
On trailing P/E, Oceaneering International, Inc.
(OII) is the cheapest at 10. 8x versus Helix Energy Solutions Group, Inc. at 47. 9x. On forward P/E, Oceaneering International, Inc. is actually cheaper at 21. 0x.
03Which is the better long-term investment — HLX or OII or TDW or CLOV or ACDC?
Over the past 5 years, Tidewater Inc.
(TDW) delivered a total return of +460. 2%, compared to -59. 8% for ProFrac Holding Corp. (ACDC). Over 10 years, the gap is even starker: HLX returned +37. 9% versus CLOV's -66. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HLX or OII or TDW or CLOV or ACDC?
By beta (market sensitivity over 5 years), ProFrac Holding Corp.
(ACDC) is the lower-risk stock at 0. 51β versus Clover Health Investments, Corp. 's 1. 36β — meaning CLOV is approximately 170% more volatile than ACDC relative to the S&P 500. On balance sheet safety, Helix Energy Solutions Group, Inc. (HLX) carries a lower debt/equity ratio of 40% versus 130% for ProFrac Holding Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — HLX or OII or TDW or CLOV or ACDC?
By revenue growth (latest reported year), Clover Health Investments, Corp.
(CLOV) is pulling ahead at 40. 3% versus -11. 4% for ProFrac Holding Corp. (ACDC). On earnings-per-share growth, the picture is similar: Oceaneering International, Inc. grew EPS 142. 4% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, TDW leads at 27. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HLX or OII or TDW or CLOV or ACDC?
Tidewater Inc.
(TDW) is the more profitable company, earning 24. 7% net margin versus -19. 0% for ProFrac Holding Corp. — meaning it keeps 24. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TDW leads at 21. 4% versus -6. 9% for ACDC. At the gross margin level — before operating expenses — TDW leads at 30. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HLX or OII or TDW or CLOV or ACDC more undervalued right now?
On forward earnings alone, Oceaneering International, Inc.
(OII) trades at 21. 0x forward P/E versus 89. 7x for Clover Health Investments, Corp. — 68. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLX: 39. 3% to $14. 00.
08Which pays a better dividend — HLX or OII or TDW or CLOV or ACDC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is HLX or OII or TDW or CLOV or ACDC better for a retirement portfolio?
For long-horizon retirement investors, ProFrac Holding Corp.
(ACDC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 51)). Both have compounded well over 10 years (ACDC: -59. 8%, CLOV: -66. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HLX and OII and TDW and CLOV and ACDC?
These companies operate in different sectors (HLX (Energy) and OII (Energy) and TDW (Energy) and CLOV (Healthcare) and ACDC (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HLX is a small-cap quality compounder stock; OII is a small-cap deep-value stock; TDW is a small-cap deep-value stock; CLOV is a small-cap high-growth stock; ACDC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.